OCTOBER 22 - 24

2026

OCTOBER 22 - 24

2026

14TH DASIL WORLD
CONGRESS

IN KOCHI | KERALA, INDIA

LATE BREAKING ABSTRACT SUBMISSION

Notification of acceptance or rejection of submitted Late Breaking abstracts will be sent to the corresponding authors via email.

LATE BREAKING ABSTRACTS

The organizers invite Authors to submit their late breaking abstracts for consideration and inclusion in the “Late breaking abstract session”.
Deadline for the submission of late breaking abstracts:
MAY 31, 2026
Abstract evaluation:
JUNE 22, 2026

SUBMISSION CRITERIA

Scientific data and results included in the late-breaking abstract submissions must be new and unpublished.

SELECTED ABSTRACTS PRESENTATION MODE

The Authors of selected abstracts will be invited to hold an oral presentation during the “Late breaking news session”.
E-posters cannot be submitted for the late-breaking news session.
The presenting author must register as a participant for the full congress.

ABSTRACT FORMALITIES

Incomplete abstracts or abstracts with formal errors will generally lead to the exclusion of abstracts!

Abstracts must be submitted as MS-Word or (editable) pdf document.
Abstracts must be submitted in English and must not exceed 300 words.
The abstract must clearly indicate the following (to be excluded from the word count):
  • Abstract title
  • Name(s) of author(s)
  • Affiliation of author(s)
  • Country of residence of author(s)
  • Current headshot for publication
The authors’ conclusion(s) should be clearly stated. General statements such as the significance of these findings will be considered unfavorably and will generally lead to the exclusion of abstracts.

Initials and abbreviations which are not in common use should be avoided unless they are essential.

Remember to check spelling and grammar carefully. Your electronically submitted abstract text will be reproduced as submitted.

SPEAKER DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST

The DASIL Society requires that all presentations must be as bias free of commercials.

It is also preferred that generic drug names be used wherever possible and that any presentation referring to unlabled or research-associated commercial products should disclose this situation to session attendees.

ABSTRACT SUBMISSION

Authors may submit their abstract(s) via email to batu_gezer(at)logi-vent.de
Only electronically submitted abstracts will be considered.

ABSTRACT EVALUATION

The DASIL Scientific Board will review all abstracts without knowledge of the author’s name. Acceptance or rejection of an abstract will be based on the average grade awarded by the review committee.

The abstract should be presented in a way that the contribution of the research to advance knowledge can be assessed.

The Scientific Board reserves the right to:
  • Select the abstracts relevant to the sessions
  • Decide on the final topic of the abstract
By submitting an abstract for the 14th DASIL World Congress, the author confirms that he/she has read and understood the terms & conditions and accepts them.